RIO DE JANEIRO (Reuters) – Pfizer Inc has delivered the results of the Phase 3 trial for its COVID-19 vaccine to Brazilian health regulator Anvisa, the regulatory body said in a statement on Wednesday.
Pfizer is the second company to do so after AstraZeneca Plc delivered its results to Anvisa earlier in December.
(Reporting by Pedro Fonseca; Writing by Gram Slattery; Editing by Brad Haynes)
